Organogenesis Holdings Inc. ORGO revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Organogenesis Holdings Inc. reported revenue across 2 products and services; the largest, Product, was $563M, 99.8% of the filed sum (+16.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$563M99.8%+16.8% yoy
- Grant$1.14M0.2%no prior
Members sum to the consolidated $564M for this period.
- Product$36.3M97.4%-58.2% yoy
- Grant$978K2.6%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.